Search

Home > Diabetes Discourse > Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Podcast: Diabetes Discourse
Episode:

Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Category: Science & Medicine
Duration: 00:00:00
Publish Date: 2023-10-25 04:00:00
Description: Host: John Buse, MD, PhD
Guest: Simon Heller, MD

Amid the crisis around the cost of diabetes care worldwide, biosimilar insulins could help save millions of dollars and allow more patients to be treated safely and effectively. But how exactly are these products approved, and how do they compare to the original product? Find out with Dr. John Buse and Dr. Simon Heller, Professor of Clinical Diabetes at the University of Sheffield and the Director of Research and Development at Sheffield Teaching Hospitals Foundation Trust in the United Kingdom. Together, they’ll review Dr. Heller’s recent paper on biosimilar basal insulins that was published in Clinical Diabetes.
Total Play: 0

Some more Podcasts by ReachMD

200+ Episodes
Primary Care .. 50+     6
200+ Episodes
Focus on Neu .. 10+     3